Literature DB >> 28524372

Herbal Formula, Baogan Yihao (BGYH), Prevented Dimethylnitrosamine(DMN)-Induced Liver Injury in Rats.

Xiujie Liu1, Jing Su1, Yu Shi2, Ying Guo1, Imran Suheryani1, Shicong Zhao1, Yulin Deng1, Weiwei Meng3, Yan Chen3, Lili Sun3, Rongji Dai1.   

Abstract

Preclinical Research Baogan Yihao (BGYH) is a traditional Chinese herbal medicine for the treatment of chronic liver diseases. In this study, the effects of BGYH on dimethylnitrosamine (DMN)-induced liver fibrosis were investigated using a rat model. BGYH alleviate liver damage, as indicated by decreased levels of AST, ALT, γ-GT, and AKP. BGYH also prevented collagen deposition and reduced pathological tissue injury in liver tissue. In fibrosis, high levels of α-SMA and TGF-β in liver tissue were markedly attenuated by BGYH. The inhibitory effect of BGYH on HSC-T6 proliferation demonstrated that BGYH exhibited significant hepatoprotective and antifibrogenic effects on DMN-induced liver injury. These findings suggest that BGYH may have therapeutic potential in the prevention and therapy of liver fibrosis. Drug Dev Res 78 : 155-163, 2017.
© 2017 Wiley Periodicals, Inc. © 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Baogan Yihao; hepatoprotective; liver injury

Mesh:

Substances:

Year:  2017        PMID: 28524372     DOI: 10.1002/ddr.21388

Source DB:  PubMed          Journal:  Drug Dev Res        ISSN: 0272-4391            Impact factor:   4.360


  2 in total

1.  Bupleurum marginatum Wall.ex DC in Liver Fibrosis: Pharmacological Evaluation, Differential Proteomics, and Network Pharmacology.

Authors:  Xiujie Liu; Yu Shi; Yinghui Hu; Ke Luo; Ying Guo; Weiwei Meng; Yulin Deng; Rongji Dai
Journal:  Front Pharmacol       Date:  2018-05-17       Impact factor: 5.810

2.  HPLC-ESI-MSn Identification and NMR Characterization of Glucosyloxybenzyl 2R-Benzylmalate Deriva-Tives from Arundina Graminifolia and Their Anti-Liver Fibrotic Effects In Vitro.

Authors:  Qingqing Liu; Feiyi Sun; Yulin Deng; Rongji Dai; Fang Lv
Journal:  Molecules       Date:  2019-01-31       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.